FCGR2A promoter variant reveals shared genetic susceptibility between IBD and stroke.

Saved in:
Bibliographic Details
Title: FCGR2A promoter variant reveals shared genetic susceptibility between IBD and stroke.
Authors: Wang X; College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, 150081, Heilongjiang, China.; National Health Commission Key Laboratory of Molecular Probes and Targeted Diagnosis and Therapy, Harbin Medical University, Harbin, 150081, China., Zhu Z; College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, 150081, Heilongjiang, China., Li H; College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, 150081, Heilongjiang, China., Gao J; College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, 150081, Heilongjiang, China.; National Health Commission Key Laboratory of Molecular Probes and Targeted Diagnosis and Therapy, Harbin Medical University, Harbin, 150081, China., Ding M; College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, 150081, Heilongjiang, China.; National Health Commission Key Laboratory of Molecular Probes and Targeted Diagnosis and Therapy, Harbin Medical University, Harbin, 150081, China., Li Y; National Health Commission Key Laboratory of Molecular Probes and Targeted Diagnosis and Therapy, Harbin Medical University, Harbin, 150081, China.; Department of Child and Adolescent Health, School of Public Health, Harbin Medical University, Harbin, 150081, China., Shi L; National Health Commission Key Laboratory of Molecular Probes and Targeted Diagnosis and Therapy, Harbin Medical University, Harbin, 150081, China. shilei_0328@hrbmu.edu.cn.; Central Laboratory-Human Molecular Genetics Group, Changde Hospital, Xiangya School of Medicine, Central South University (The First People's Hospital of Changde City), Changde, 415000, Hunan, China. shilei_0328@hrbmu.edu.cn., Zhu S; Medical School, South China Hospital, Institute of Medical Information, Shenzhen University, Shenzhen, 518116, China. zhushimao1118@163.com., Cheng L; College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, 150081, Heilongjiang, China. liangcheng@hrbmu.edu.cn.; National Health Commission Key Laboratory of Molecular Probes and Targeted Diagnosis and Therapy, Harbin Medical University, Harbin, 150081, China. liangcheng@hrbmu.edu.cn.
Source: Molecular and cellular biochemistry [Mol Cell Biochem] 2026 Jul 04. Date of Electronic Publication: 2026 Jul 04.
Publication Type: Journal Article
Journal Info: Publisher: Springer Country of Publication: Netherlands NLM ID: 0364456 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-4919 (Electronic) Linking ISSN: 03008177 NLM ISO Abbreviation: Mol Cell Biochem Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1573-4919
DOI:10.1007/s11010-026-05631-w